Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Calcium folinate
Indication: 1. Used for follow-up treatment of high-dose methotrexate to reduce toxicity (calcium folinate rescue). Also used to treat patients with negligent methotrexate overdose and impaired methotrexate excretion. Combined with fluorouracil, it can improve the efficacy of fluorouracil and is commonly used in the treatment of colorectal cancer and gastric cancer. 2. Also used for megaloblastic anemia caused by sprue, malnutrition, pregnancy or infancy. It is not suitable for vitamin B12 deficiency anemia when oral folic acid is ineffective.
Manufacturer:
Huzhou Zhanwang Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
Hubei Fuguang Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
BESTWAY Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
Heilongjiang Ruige Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.
Compound fluorouracil oral solution
Indication: Used for the treatment of digestive tract cancer (colon cancer, rectal cancer, gastric cancer), breast cancer, primary liver cancer and other cancers.
Manufacturer:
North China Pharmaceutical Company.Ltd
Related Ingredients